Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study
Background. Novel agents immune checkpoint inhibitors fundamentally changed the prognosis for life in patients with metastatic and/or inoperable melanoma. The development, studies, and approval of a new original PD1 inhibitor in Russia in 2020 prompted the professional community to conduct a prosp...
Similar Items
-
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01) -
The Influence of Cationic Nitrosyl Iron Complex with Penicillamine Ligands on Model Membranes, Membrane-Bound Enzymes and Lipid Peroxidation
by: Darya A. Poletaeva, et al.
Published: (2022-11-01) -
New varieties of vegetable cowpea (<i>Vigna unguiculata</i> subsp. <i>sesquipedalis </i>(L.) Verdc.) and prospects of their cultivation in southern Russia
by: Marina O. Burlyaeva, et al.
Published: (2019-11-01) -
Influence of Nitrosyl Iron Complex with Thiosulfate Ligands on Therapeutically Important Targets Related to Type 2 Diabetes Mellitus
by: Irina I. Faingold, et al.
Published: (2023-06-01) -
Characteristics of insulin therapy of diabetes mellitus type 1 in children and adolescents receiving glucocorticoids
by: Alisa V. Vitebskaya, et al.
Published: (2019-08-01)